Time for a little end-of-the-quarter pause here at OnBioVC as we are compiling data and preparing the 3Q10 Trend Analysis for release next week. While taking a deep breath here are some interesting 3Q10 highlights.
The following fund closings were recently announced and total in excess of $1 billion in new life science risk capital ready [...]

The ‘Looking for Some (More) of This?’ series is focused upon the tracking of newly formed venture funds who are financing biomedical innovation.
Whilst many continue to pound the drum echoing the sentiment that limited partners remain sidelined, here is additional demonstration of continued new capital formation in the life science sector, courtesy of OrbiMed, who [...]